Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T15:07:44.796Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:07:44.796Z.

Quote observation: 2026-10-06T15:04:35.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 155,606,258
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 24,652,086
TTM free cash flow · period ending 2026-06-30: -18,779,281,838

FMP input reference: cfadd87817ab9e0f0725aca527bf69eaa76c8d0ff583b2c20c0f03a80ea5973c

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

NERV EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

EV/FCF RATIO AVG TTM

N/A

EV/FCF RATIO AVG 3Y

N/A

EV/FCF RATIO AVG 5Y

N/A

EV/FCF RATIO AVG 10Y

N/A

EV/FCF RATIO AVG 15Y

N/A

EV/FCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

NERV Competitors' EV/FCF Ratio

NERV

Minerva Neurosciences, Inc.

Current

Market Cap

$155.61M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MENS

Jyong Biotech Ltd. Ordinary Shares

vs NERV

Market Cap

$155.86M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LFMDP

LifeMD, Inc.

vs NERV

Market Cap

$154.72M

EV/FCF Ratio

N/A

TTM Avg

175.94x

3Y Avg

1237.69x

5Y Avg

1237.69x

INGN

Inogen, Inc.

vs NERV

Market Cap

$156.63M

EV/FCF Ratio

N/A

TTM Avg

55.26x

3Y Avg

38.45x

5Y Avg

50.33x

ALXO

ALX Oncology Holdings Inc.

vs NERV

Market Cap

$154.07M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRDL

Cardiol Therapeutics Inc.

vs NERV

Market Cap

$153.89M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CDXS

Codexis, Inc.

vs NERV

Market Cap

$152.74M

EV/FCF Ratio

N/A

TTM Avg

40.01x

3Y Avg

40.01x

5Y Avg

40.01x

AVXL

Anavex Life Sciences Corp.

vs NERV

Market Cap

$151.52M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ABOS

Acumen Pharmaceuticals, Inc.

vs NERV

Market Cap

$150.23M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NGEN

NervGen Pharma Corp. Common stock

vs NERV

Market Cap

$147.54M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Minerva Neurosciences, Inc. (NERV)	$155.61M	N/A	N/A	N/A	N/A
Jyong Biotech Ltd. Ordinary Shares (MENS)vs ›	$155.86M	N/A	N/A	N/A	N/A
LifeMD, Inc. (LFMDP)vs ›	$154.72M	N/A	175.94x	1237.69x	1237.69x
Inogen, Inc. (INGN)vs ›	$156.63M	N/A	55.26x	38.45x	50.33x
ALX Oncology Holdings Inc. (ALXO)vs ›	$154.07M	N/A	N/A	N/A	N/A
Cardiol Therapeutics Inc. (CRDL)vs ›	$153.89M	N/A	N/A	N/A	N/A
Codexis, Inc. (CDXS)vs ›	$152.74M	N/A	40.01x	40.01x	40.01x
Anavex Life Sciences Corp. (AVXL)vs ›	$151.52M	N/A	N/A	N/A	N/A
Acumen Pharmaceuticals, Inc. (ABOS)vs ›	$150.23M	N/A	N/A	N/A	N/A
NervGen Pharma Corp. Common stock (NGEN)vs ›	$147.54M	N/A	N/A	N/A	N/A

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

NERV EV/FCF Ratio History

DATE	EV/FCF RATIO
2018-05-03	69.91x
2018-05-02	78.06x
2018-05-01	76.18x
2018-04-30	74.93x
2018-04-27	73.36x
2018-04-26	78.06x
2018-04-25	78.69x
2018-04-24	84.32x
2018-04-23	84.32x
2018-04-20	83.07x
2018-04-19	82.44x
2018-04-18	83.70x
2018-04-17	83.07x
2018-04-16	79.31x
2018-04-13	79.31x
2018-04-12	81.82x
2018-04-11	79.94x
2018-04-10	78.69x
2018-04-09	76.18x
2018-04-06	78.06x
2018-04-05	79.31x
2018-04-04	84.95x
2018-04-03	75.55x
2018-04-02	70.54x
2018-03-29	71.17x
2018-03-28	72.42x
2018-03-27	68.66x
2018-03-26	74.30x
2018-03-23	73.05x
2018-03-22	74.30x
2018-03-21	76.81x
2018-03-20	76.18x
2018-03-19	76.18x
2018-03-16	71.79x
2018-03-15	72.42x
2018-03-14	73.67x
2018-03-13	73.67x
2018-03-12	68.96x
2018-03-09	66.30x
2018-03-08	63.64x
2018-03-07	65.63x
2018-03-06	62.31x
2018-03-05	60.98x
2018-03-02	58.99x
2018-03-01	57.00x
2018-02-28	59.66x
2018-02-27	62.98x
2018-02-26	66.30x
2018-02-23	63.64x
2018-02-22	58.99x
2018-02-21	60.32x
2018-02-20	58.66x
2018-02-16	62.31x
2018-02-15	62.98x
2018-02-14	64.97x
2018-02-13	64.31x
2018-02-12	63.64x
2018-02-09	63.64x
2018-02-08	65.63x
2018-02-07	71.61x
2018-02-06	64.31x
2018-02-05	66.30x
2018-02-02	72.28x
2018-02-01	75.60x
2018-01-31	74.94x
2018-01-30	72.94x
2018-01-29	70.95x
2018-01-26	77.59x
2018-01-25	82.91x
2018-01-24	80.25x
2018-01-23	77.59x
2018-01-22	78.26x
2018-01-19	80.25x
2018-01-18	76.93x
2018-01-17	76.93x
2018-01-16	76.26x
2018-01-12	72.94x
2018-01-11	70.29x
2018-01-10	62.98x
2018-01-09	60.98x
2018-01-08	63.64x
2018-01-05	69.62x
2018-01-04	70.29x
2018-01-03	71.61x
2018-01-02	72.28x
2017-12-29	70.29x
2017-12-28	74.27x
2017-12-27	71.61x
2017-12-26	74.94x
2017-12-22	70.29x
2017-12-21	72.94x
2017-12-20	66.96x
2017-12-19	64.97x
2017-12-18	66.96x
2017-12-15	68.96x
2017-12-14	66.30x
2017-12-13	70.95x
2017-12-12	67.63x
2017-12-11	70.29x
2017-12-08	65.63x
2017-12-07	64.31x
2017-12-06	58.99x
2017-12-05	61.65x
2017-12-04	64.31x
2017-12-01	63.64x
2017-11-30	66.30x
2017-11-29	70.29x
2017-11-28	64.31x
2017-11-27	59.66x
2017-11-24	60.98x
2017-11-22	61.65x
2017-11-21	58.99x
2017-11-20	59.66x
2017-11-17	58.99x
2017-11-16	58.99x
2017-11-15	57.66x
2017-11-14	58.33x
2017-11-13	55.67x
2017-11-10	58.99x
2017-11-09	56.33x
2017-11-08	57.66x
2017-11-07	61.65x

EV/FCF Ratio: N/A

NERV EV/FCF Ratio Chart

NERV EV/FCF Ratio Metrics

NERV Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

NERV EV/FCF Ratio History

Related Metrics